FENC
Fennec Pharmaceuticals Inc.
1W: -17.4%
1M: -30.8%
3M: -19.8%
YTD: -19.7%
1Y: -6.5%
3Y: -23.6%
5Y: -14.7%
$6.17
+0.15 (+2.49%)
After Hours: $6.57 (+0.40, +6.48%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$176.3M
52W Range4.68-9.92
Volume371,746
Avg Volume150,827
Beta1.45
Dividend—
Analyst Ratings
Company Info
CEOJeffrey S. Hackman
Employees32
SectorHealthcare
IndustryBiotechnology
IPO Date2017-09-15
Websitefennecpharma.com
68 TW Alexander Drive
Research Triangle Park, NC 27709
US
Research Triangle Park, NC 27709
US
919 636 4530
About Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
Latest News
Adherex Technologies Inc. (FENC) Reports Q4 Loss, Misses Revenue Estimates
Fennec Pharmaceuticals GAAP EPS of -$0.17 misses by $0.21, revenue of $13.78M misses by $0.95M
Earnings Scheduled For March 24, 2026
Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Raykov Rosty | M-Exempt | 15,598 | $2.45 | 2026-03-02 |
| Raykov Rosty | S-Sale | 10,079 | $8.36 | 2026-03-02 |
| Raykov Rosty | M-Exempt | 15,598 | $2.45 | 2026-03-02 |
| Andrade Robert | A-Award | 1,191 | — | 2026-02-28 |
| Raykov Rosty | A-Award | 5,208 | — | 2026-02-28 |